REQUEST A DEMO
Total
USD $0.00
Search more companies

DR. MEGYESI PHARMA Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: DR. MEGYESI PHARMA Kft. Profile Updated: April 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

DR. MEGYESI PHARMA Kft. is based in Hungary. The head office is in Budapest. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. The company was established on June 12, 2015. It currently has a total number of 4 (2016) employees. There was a net sales revenue drop of 33.15% reported in DR. MEGYESI PHARMA Kft.’s latest financial highlights for 2024. Its’ total assets recorded a negative growth of 2.18%. The net profit margin of DR. MEGYESI PHARMA Kft. increased by 0.23% in 2024.

Headquarters
Nagytetenyi ut 222.
Budapest; Budapest; Postal Code: 1225

Contact Details: Purchase the DR. MEGYESI PHARMA Kft. report to view the information.

Website: http://www.veyx.hu

Basic Information
Total Employees:
Purchase the DR. MEGYESI PHARMA Kft. report to view the information.
Registered Capital:
Purchase the DR. MEGYESI PHARMA Kft. report to view the information.
Financial Auditors:
Purchase the DR. MEGYESI PHARMA Kft. report to view the information.
Incorporation Date:
June 12, 2015
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Diapolo Sport Kft.
Company Performance
Financial values in the chart are available after DR. MEGYESI PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-33.15%
Total Operating Revenue
-33.77%
Operating Profit
-5.62%
EBITDA
-8.02%
Net Profit/Loss for the Period
-25.45%
Total Assets
-2.18%
Total Equity
1.78%
Operating Profit Margin
0.79%
Net Profit Margin
0.23%
Return on Equity (ROE)
-0.64%
Quick Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?